[在患有严重皮肤反应的患者中,使用Temozolomide成功降敏的案例]
Pamela Salman1, Magdalena Abbott-Croxatto1, Camila Urrea1
1Centro de responsabilidad Hemato-oncología, Hospital San Juan de Dios, Santiago, Chile.
Revista medica de Chile
|December 17, 2025
概括
在发生严重皮肤反应后,质母细胞瘤患者可以安全地使用脱敏方案继续使用temozolomide治疗. 这种方法可以完成必要的化疗周期,并具有可控的副作用.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多形质母细胞瘤是一种主要的大脑瘤,需要积极的治疗.
- 泰莫佐洛米德是用于质母细胞瘤的标准辅助化疗剂.
- 严重的皮肤学不良事件可能需要停止治疗.
研究的目的:
- 评估在发生严重皮疹的质母细胞瘤患者中使用temozolomide脱敏化方案的安全性和有效性.
- 为了确定脱敏是否允许继续辅助泰莫索洛米德治疗.
主要方法:
- 一名患有质母细胞瘤的患者在接受temozolomide治疗期间出现了广泛的黄斑状皮疹.
- 为了管理严重的皮肤反应,启动了脱敏方案.
- 患者接受了5个循环的治疗,使用了脱敏方案.
主要成果:
- 患者成功完成了所有12个计划的治疗周期.
- 脱敏方案在治疗皮疹方面是有效的,在最初的脱敏周期中,只有轻微的症状.
- 持续使用temozolomide的结果是没有重复严重的不良事件.
结论:
- 泰莫佐洛米德脱敏是一种可行且安全的策略,用于发生严重皮肤不良反应的质母细胞瘤患者.
- 该协议使关键辅助化疗的完成成为可能,改善了治疗坚持和潜在的患者结果.
相关概念视频
01:30Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
01:20Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K